People on the Move
Isogenica
Isogenica, a discovery services company specialising in peptides, proteins and antibodies, has promoted an internal hire to CEO.
Chris Ullman, who joined the company in 2002 and was promoted to Chief Scientific Officer in 2009, will lead the company from September 29 when Kevin Matthews leaves for polymer tech company Revolymer.
Isogenica’s Chairman said the new CEO had been “instrumental” to the company’s strategy in his previous roles. “Dr Ullman has worked closely with Dr. Matthews over the last five years and has been at the heart of delivering a fundamental change in the capability and direction of the business,” said Jan-Olof Lundin.